Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 5Other hematologic neoplasm 3Gynecologic 3Genitourinary 2Myeloid 1Head & Neck 1

Conditions

Carcinoma, Renal Cell 2Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasms 1Kidney Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 183Magnetic Resonance Spectroscopy 163Specimen Handling 135enzalutamide 126Nivolumab 125Gemcitabine 99Docetaxel 96Radiosurgery 92Prednisone 85Androgen Antagonists 82Abiraterone Acetate 81Radiotherapy 75apalutamide 68Cisplatin 65darolutamide 63Ipilimumab 63Biopsy 61abiraterone 58cabozantinib 56Carboplatin 56Leuprolide 53enfortumab vedotin 50Radiation 48Pluvicto 45Standard of Care 44atezolizumab 41Surveys and Questionnaires 39acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37X-Rays 37avelumab 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Tyrosine Kinase Inhibitors × Genitourinary × 1 year × Clear all
NCT04777994 2026-06-04

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Calico Life Sciences LLC

Phase 1 Recruiting
248 enrolled
GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasms, Recurrence

NCT04508725 2025-07-25

Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC)

Stanford University

Phase NA Completed
22 enrolled 16 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡